FCPA Compliance and Ethics Report-Episode 15-GSK in China: a Game Changer in Compliance

more+
less-
In this Episode 15, I am interviewed by Mary Flood about my recent eBook, GSK in China: a Game Changer in Compliance. I believe that this case will be one of the most significant international anti-corruption developments in recent years and I discuss its implications for all western companies doing business in China.

Embed Video

Copy

Topics:  Anti-Corruption, Chief Compliance Officers, China, Compliance, Ethics, FCPA, GlaxoSmithKline

Published In: Franchise Updates, International Trade Updates, Mergers & Acquisitions Updates, Securities Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomas Fox | Attorney Advertising

Other Videos by Thomas Fox